How Syngene developed a multi-drug combination, antiparasitic drug for dogs for a leading Animal Health company
Learn how Syngene developed an antiparasitic tablet for dogs containing multiple APIs (one of which is a very low dose) in just six months.
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)
Publication: Journal of Medicinal Chemistry
Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series
Publication: Journal of Medicinal Chemistry
Solvent-Dependent Photophysics and Reactivity of Monomeric and Dimeric 4-Amino-1,8-Naphthalimides
Publication: The Journal of Physical Chemistry A
Synthetic platform for mono-functionalised tridentate macrocycles as key precursors of mechanically-linked macromolecular systems
Publication: Organic Chemistry Frontiers
US FDA approved drugs from 2015-June 2020-A perspective
Publication: Journal of Medicinal Chemistry
Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia
Publication: Leukemia
A novel reactor configuration for continuous virus inactivation
Publication: Biochemical Engineering Journal
Palladium‐Catalyzed Reductive Carbonylation of (Hetero) Aryl Halides and Triflates Using Cobalt Carbonyl as CO Source
Publication: Europen Journal of Organic Chemistry
Lead Optimization of a Pyrrole-Based Dihydroorotate
Publication: Journal of Medicinal Chemistry
